Yellow Fever Vaccine Trial - U44 Clinical Trial with Najit

Clinical Trial Grant

Duke Scholars

Principal Investigator Christopher Wildrick Woods Medicine, Infectious Diseases

Co-Principal Investigator Emmanuel Benjamin Walter Jr. Pediatrics, General Pediatrics and Adolescent Health

Administered By

Duke Human Vaccine Institute

Awarded By

Najit Technologies, Inc.

Start Date

July 2, 2021

End Date

June 30, 2024

Administered By

Duke Human Vaccine Institute

Awarded By

Najit Technologies, Inc.

Start Date

July 2, 2021

End Date

June 30, 2024